Copyright
©The Author(s) 2018.
World J Gastroenterol. Nov 14, 2018; 24(42): 4798-4808
Published online Nov 14, 2018. doi: 10.3748/wjg.v24.i42.4798
Published online Nov 14, 2018. doi: 10.3748/wjg.v24.i42.4798
Total No. (n) | ESRD cases (n) | Person-years | ESRD incidence (per 1000 person-years) | Crude HR (95%CI) | P value | Model 11 HR (95%CI) | P value | Model 22 HR (95%CI) | P value | Model 33 HR (95%CI) | P value | |
Total IBD | 0.009 | 0.009 | < 0.001 | < 0.001 | ||||||||
Non-IBD control | 116436 | 166 | 568575 | 0.29 | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | ||||
IBD cohort | 38812 | 79 | 189245 | 0.42 | 1.43 (1.09-1.87) | 1.43 (1.09-1.87) | 1.67 (1.27-2.18) | 3.03 (1.77-5.20) | ||||
IBD subgroup | 0.013 | 0.004 | < 0.001 | < 0.001 | ||||||||
Non-IBD control | 116436 | 166 | 568575 | 0.29 | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | ||||
Incident IBD group | 16606 | 32 | 65646 | 0.49 | 1.71 (1.17-2.50) | 1.89 (1.29-2.73) | 1.72 (1.17-2.52) | 3.06 (1.71-5.47) | ||||
Prevalent IBD group | 22206 | 47 | 123600 | 0.38 | 1.29 (0.93-1.78) | 1.23 (0.89-1.70) | 1.63 (1.18-2.27 | 3.01 (1.67-5.43) |
- Citation: Park S, Chun J, Han KD, Soh H, Choi K, Kim JH, Lee J, Lee C, Im JP, Kim JS. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol 2018; 24(42): 4798-4808
- URL: https://www.wjgnet.com/1007-9327/full/v24/i42/4798.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i42.4798